Casirivimab and imdevimab reduced mortality in seronegative patients with COVID-19
1. All-cause mortality at 28 days was significantly higher in the usual care group compared to the casirivimab and imdevimab ...
1. All-cause mortality at 28 days was significantly higher in the usual care group compared to the casirivimab and imdevimab ...
1. Patients hospitalized with COVID-19 receiving at least one dose of molnupiravir did not show reduced mortality compared to patients ...
1. Milrinone was shown not to be significantly different than dobutamine for the treatment of cardiogenic shock. 2. In-hospital deaths ...
1. Among patients hospitalized with severe COVID-19 and hyperinflammation, treatment using the anti-interleukin-1β antibody canakinumab, compared with placebo, did not ...
1. This phase III drug trial showed that dexamethasone does not significantly reduce risk of adverse events and death following ...
1. Patients with prior episodes of critical illness requiring ICU admission were found to have an elevated risk of suicide ...
1. Treatment with dexmedetomidine was shown not to differ from propofol treatment in adult patients with sepsis who were under ...
1. In this single center quality improvement study, the use of any volume-targeted ventilation in premature infants increased by 16%, and ...
1. In a single center quality improvement project, implementation of a clinical practice algorithm in mechanically ventilated patients in the ...
1. A web-based decision aid was developed to help improve communication between clinicians and patient-surrogates for patients with prolonged mechanical ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.